Labshake search
Citations for Stemcell Technologies :
651 - 700 of 2054 citations for Human Low affinity immunoglobulin gamma Fc region receptor II c FCGR2C ELISA Kit since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cancer Biology 2021Quote: Bone marrows of sacrificed mice were extracted and human cells were separated according to expression of human CD45 (EasySep™, StemCell Technologies, Vancouver, Canada). Libraries were prepared using 10X Genomics technology (see supplemental information).
-
bioRxiv - Microbiology 2020Quote: Bone marrow-derived primary human CD34+ HSPCs (Stem Cell Technologies) were cultured in erythroid differentiation medium (cPIMDM ...
-
bioRxiv - Genomics 2020Quote: ... CD34+ human cord blood cells were obtained from StemCell Technologies, and long-term CD34+ HSPC cultures were established by overexpression of AML1-ETO or AML1-ETO-FKBP12F36V as previously described23 ...
-
bioRxiv - Molecular Biology 2019Quote: Human primary CD8+ T cells were purchased from STEMCELL Technologies Inc ...
-
bioRxiv - Cancer Biology 2019Quote: ... 20 ng/ml human recombinant epidermal growth factor (StemCell Technologies), 1% Penicillin/Streptomycin (Gibco ...
-
bioRxiv - Bioengineering 2021Quote: ... Human iPS cells were cultured in mTeSR1 (StemCell Technologies; 85870) medium without antibiotics and split (1:6 ...
-
bioRxiv - Microbiology 2020Quote: ... Immunocult human CD3/CD28 T cell activator (STEMCELL Technologies, USA) was used to stimulate the PBMCs as a positive control for immunological activation.
-
bioRxiv - Immunology 2022Quote: ... and recombinant human EGF (10 ug/mL; Stem Cell Technologies) in 10% DMSO before long-term cryopreservation (1X107 cells/mL ...
-
bioRxiv - Microbiology 2020Quote: Commercial Intesticult (INT) human organoid growth medium (Stem Cell Technologies), composed of components A and B ...
-
bioRxiv - Pharmacology and Toxicology 2020Quote: Human cord blood CD34+ cells were purchased from STEMCELL Technologies GmbH (Cologne ...
-
bioRxiv - Neuroscience 2020Quote: ... Human iPSCs were maintained in complete mTeSR1 medium (STEMCELL Technologies) on Matrigel (Corning ...
-
bioRxiv - Bioengineering 2021Quote: ... Primary human peripheral blood CD8+ T cells (Stemcell Technologies - #70027) were expanded using fresh complete ImmunoCult™-XF T Cell Expansion Medium (Stemcell Technologies - #10981 ...
-
bioRxiv - Genetics 2021Quote: ... or ReLeSR Human Pluripotent Stem Cell Passaging Reagent (STEMCELL Technologies), and maintained on media supplemented with the ROCK1 inhibitor Y-27632 (10 µM ...
-
bioRxiv - Cancer Biology 2022Quote: ... Human T cells from anonymous donors sourced by STEMCELL Technologies were isolated by negative selection for CD3+ populations as per manufacturer’s instruction (EasySep ...
-
bioRxiv - Cell Biology 2022Quote: ... and fed with human IntestiCult Organoid Growth Media (STEMCELL technologies). 96 hours after plating ...
-
bioRxiv - Microbiology 2023Quote: ... bone marrow primary human CD34+ HSPCs (Stem Cell Technologies; AllCells) were cultured in PIMDM composed of Iscove Basal Medium (Sigma ...
-
bioRxiv - Immunology 2023Quote: ... Human iPSCs were cultured in mTeSR medium (85852, STEMCELL Technologies) with Matrigel Matrix (354277 ...
-
bioRxiv - Immunology 2023Quote: ... or ImmunoCult Human CD3/CD28 T cell activator (Stemcell Technologies) was added at a dilution of 1:500.
-
bioRxiv - Cancer Biology 2022Quote: ... human bFGF (10 ng/ml, Stem Cell Technologies, cat# 78003) and human EGF (20 ng/ml ...
-
bioRxiv - Neuroscience 2023Quote: Human embryonic stem cells were cultured in mTESR (Stemcell technologies) on matrigel (Corning) ...
-
Single-cell profiling and zebrafish avatars reveal LGALS1 as immunomodulating target in glioblastomabioRxiv - Cancer Biology 2023Quote: ... supplemented with NeuroCult NS-A Proliferation Supplement (human, STEMCELL Technologies), heparin solution (2 mg/mL ...
-
bioRxiv - Biochemistry 2023Quote: ... 10 ng/ml human epidermal growth factor (STEMCELL Technologies, 78006), 20 ng/mL basic fibroblast growth factor (STEMCELL Technologies ...
-
bioRxiv - Neuroscience 2024Quote: ... 20 ng/ml Human Recombinant GDNF (#78058; Stem Cell Technology), 1 mM Dibutyryl-cAMP (#73882 ...
-
bioRxiv - Neuroscience 2024Quote: ... 20 ng/ml Human Recombinant BDNF (#78005; Stem Cell Technology), 20 ng/ml Human Recombinant GDNF (#78058 ...
-
bioRxiv - Immunology 2023Quote: B cells subsets were obtained from WT or IL17 −/− naïve mice or from mice 14 d after alloantigen immunization (2 × 10 7 mitomycin C–treated BALB/c splenocytes i.p.) by negative selection (EasySep; StemCell Technologies). Purity of the B cell subset was greater than 98% ...
-
bioRxiv - Neuroscience 2021Quote: ... 0.5mM c- AMP (Stem Cell Technologies Cat # 73886), 20ng/ml BDNF (Stem Cell Technologies Cat # 78005) ...
-
bioRxiv - Physiology 2019Quote: Monocytes were isolated by the University of Pennsylvania Human Immunology Core from healthy apheresis donors with institutional review board approval by RosetteSep™ human monocyte enrichment cocktail (Stem Cell Technologies, Vancouver, Canada), and MΦs were differentiated by 12-days adherence culture in RPMI 1640 media containing 10% human serum and 1x cell culture pen/strep antibiotic mix (Gibco) ...
-
bioRxiv - Cancer Biology 2021Quote: ... and were plated in a concentration of 9,000 cells/well into an ultra-low-binding 96-well plate in mTeSR™1 medium (Stemcell technologies) containing Rho-associated protein kinase (ROCK ...
-
bioRxiv - Immunology 2022Quote: ... diluted in MethoCult GF-M3434 medium and plated at 20,000 cells/35 mm well in a 6-well plate of low-adherence culture-ware (STEMCELL Technologies, Inc.), in triplicate ...
-
bioRxiv - Neuroscience 2022Quote: ... Harvested spheroids then were transferred into 10-cm ultra-low adhesion plates in Essential 6 medium containing dual SMAD pathway inhibitors [100 nM LDN193189 (STEMCELL Technologies) and 10 μM SB431542] and 2.5 μM XAV939 (Cayman) ...
-
bioRxiv - Neuroscience 2022Quote: ... the dissociated cells were transferred to individual low-adherence V-bottom 96-well plates (S-Bio Prime) in 150μl TeSR5/6 media (StemCell Technologies®) with 50μM Rock inhibitor Y-27632 (Tocris BioScience) ...
-
bioRxiv - Pathology 2022Quote: ... and plated onto low attachment V-type 96-well plate at 20 000 cells per well or AggreWell800 plate (Stemcell Technologies) to form aggregates ...
-
bioRxiv - Immunology 2020Quote: ... larvae were tricaine-anesthetized and embedded within optically clear glass imaging cubes (Mizar Imaging) in embryo medium with 1% low melt agarose and 20% OptiPrep (Stemcell Technologies, Inc. ...
-
bioRxiv - Cancer Biology 2023Quote: The six basal- and luminal-like cell lines were disassociated with 0.25% trypsin and added individually to wells of a 6 well Ultra-low attachment plate in 2 mL Mammocult culturing media (STEMCELL Technologies). Accutase (STEMCELL Technologies ...
-
bioRxiv - Cancer Biology 2022Quote: ... cells were washed in IMDM+20%FCS and plated into 1.4 mL of cytokine-rich methylcellulose (Methocult H4435, Stem Cell Technologies). Colonies were scored 14 days later under an inverted microscope ...
-
bioRxiv - Synthetic Biology 2019Quote: ... The resulting CD34+ HSPCs were cultured in StemSpan SFEM II (STEMCELL Technologies Inc.) supplemented with 1% penicillin/streptomycin/amphotericin B (PSA ...
-
bioRxiv - Genomics 2020Quote: HUDEP-2 cell lines were cultured in StemSpan™ SFEM II (STEMCELL Technologies) along with 50 ng/ml SCF (ImmunoTools) ...
-
bioRxiv - Cell Biology 2024Quote: ... HSPCs were isolated and cultured in StemSpan SFEM II (StemCell Technologies cat. #09605) with 10 ng/mL recombinant murine SCF (STEMCELL Technologies ...
-
bioRxiv - Cancer Biology 2021Quote: Human iPSCs were grown in mTeSR or E8 medium (STEMCELL Technologies) as described (17) ...
-
bioRxiv - Molecular Biology 2020Quote: ... and human cytokine cocktail (StemSpan™ CC100, Stemcell Technologies, Cat.No. 02690). The seeded cells were then treated with ...
-
bioRxiv - Molecular Biology 2020Quote: ... and human cytokine cocktail (StemSpan™ CC100, Stemcell Technologies, Cat.No. 02690). The seeded cells were treated with MEISi-1 and MEISi-2 small molecules at 0,1 µM ...
-
bioRxiv - Molecular Biology 2020Quote: Human cells were grown in NeuroCult medium (StemCell Technologies, Vancouver, BC) supplemented with human-EGF at 20 ng/mL and human-bFGF at 20 ng/mL supplemented with penicillin/streptomycin ...
-
bioRxiv - Molecular Biology 2021Quote: ... recombinant human basic FGF (20ng/mL, all from Stem Cell Technologies) and 10 ng/ml laminin (Sigma Aldrich) ...
-
bioRxiv - Bioengineering 2020Quote: Human cord blood or mobilized peripheral blood CD34+ HSCs (StemCell Technologies) were differentiated into enucleated RBCs using a modified version of a previously-described protocol11 ...
-
bioRxiv - Bioengineering 2021Quote: Human peripheral blood cells (PBMCs) were purchased from STEMCELL Technologies (#70025). 100M PBMCs were thawed in 100 mL X-VIVO™ 10 media from Lonza (#04-380Q ...
-
bioRxiv - Immunology 2020Quote: Human peripheral blood mononuclear cells were purchased from Stemcell Technologies (#70025) and CD8+ T cells isolated using the EasySep Human CD8+ T Cell Isolation kit (Stemcell Technologies ...
-
bioRxiv - Physiology 2020Quote: ... enteroids were maintained in Human IntestiCult components A+B (STEMCELL Technologies). To promote differentiation ...
-
bioRxiv - Neuroscience 2021Quote: ... 20 ng/ml Recombinant Human Glial-Derived Neurotrophic Factor (StemCell Technologies), 1 mM Dibutyryl-cAMP (PeproTech) ...
-
bioRxiv - Neuroscience 2021Quote: ... 20 ng/ml Recombinant Human Brain-Derived Neurotrophic Factor (StemCell Technologies), 20 ng/ml Recombinant Human Glial-Derived Neurotrophic Factor (StemCell Technologies) ...
-
bioRxiv - Immunology 2022Quote: ... and human BAFF46 in 80 mL StemCell medium A (StemCell Technologies) containing 6.3 μg/mL of CpG (phosphorothioate-modified oligodeoxynucleotide ZOEZOEZZZZZOEEZOEZZZT ...